Favorites Sign in
  1. Home
  2. Companies
  3. Stock Armata Pharmaceuticals
Armata Pharmaceuticals logo

Armata Pharmaceuticals ARMP

$ 3.16 5.69%
report update icon

Quarterly report 2026-Q2
added 08-12-2026

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NYSE AMERICAN

Shares

 36.2 M

Market Cap[1]

 $ 115 M

EBITDA (LTM)

 $ -35.1 M

P/E (LTM)

 -1.216667

P/S (LTM)

 -

EPS (LTM)

 -4.8

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Evelo Biosciences Evelo Biosciences
EVLO
 		- -14.46 % $ 27.9 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Morphic Holding Morphic Holding
MORF
 		- - $ 2.42 B Nasdaq Global Market usaUSA
Novan Novan
NOVN
 		- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
 		- -15.0 % $ 3.04 M Nasdaq Global Select Market usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
 		- -9.21 % $ 2.55 M Nasdaq Global Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BELLUS Health BELLUS Health
BLU
 		- - $ 2.47 B Nasdaq Global Select Market canadaCanada
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
 		- - $ 13.6 B Nasdaq Global Select Market,SPB usaUSA
IGM Biosciences IGM Biosciences
IGMS
 		- - $ 76.9 M Nasdaq Global Select Market,SPB usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
 		- - $ 29.6 M Nasdaq Global Select Market usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
 		- - $ 216 M Nasdaq Global Market usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		- - $ 35.4 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
 		- - $ 728 M Nasdaq Global Select Market usaUSA
Rubius Therapeutics Rubius Therapeutics
RUBY
 		- -33.55 % $ 7.81 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
 		- -1.38 % $ 46.8 M Nasdaq Capital Market usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
 		- - $ 3.3 B Nasdaq Global Select Market,SPB usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
 		- - $ 309 M Nasdaq Global Select Market usaUSA
Allogene Therapeutics Allogene Therapeutics
ALLO
 		$ 1.19 5.8 % $ 263 M Nasdaq Global Select Market,SPB usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
 		- -37.48 % $ 476 K Nasdaq Capital Market usaUSA
Epizyme Epizyme
EPZM
 		- - $ 249 M Nasdaq Global Select Market usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
 		- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
 		$ 1.93 -0.77 % $ 2.53 M Nasdaq Global Select Market usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
 		- -0.75 % $ 18.7 M Nasdaq Capital Market danmarkDanmark
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		- 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		- - $ 154 M Nasdaq Capital Market usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
 		- - $ 300 M Nasdaq Global Select Market usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
 		- - $ 4.55 M Nasdaq Global Select Market irlandaIrlanda
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
 		- - $ 643 M Nasdaq Global Select Market,SPB usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
 		- - $ 127 M Nasdaq Global Select Market,SPB usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
 		- - $ 155 M Nasdaq Global Select Market usaUSA
9 Meters Biopharma 9 Meters Biopharma
NMTR
 		- -42.97 % $ 1.05 M Nasdaq Global Select Market usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
 		- - $ 2.6 B Nasdaq Global Select Market usaUSA
Lumos Pharma Lumos Pharma
LUMO
 		- - $ 35.3 M Nasdaq Global Select Market usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
 		- -8.44 % $ 3.4 M Nasdaq Global Select Market usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
 		- -18.25 % $ 5.04 M Nasdaq Global Market israelIsrael
GT Biopharma GT Biopharma
GTBP
 		$ 4.89 -7.12 % $ 27 M Nasdaq Capital Market usaUSA
Aravive Aravive
ARAV
 		- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
MannKind Corporation MannKind Corporation
MNKD
 		$ 3.94 5.63 % $ 1.2 B Nasdaq Global Market usaUSA
MediWound Ltd. MediWound Ltd.
MDWD
 		$ 14.17 5.83 % $ 386 M Nasdaq Global Select Market israelIsrael
Intellia Therapeutics Intellia Therapeutics
NTLA
 		$ 12.3 3.67 % $ 1.33 B Nasdaq Global Market,SPB usaUSA
Oramed Pharmaceuticals Oramed Pharmaceuticals
ORMP
 		$ 4.12 3.0 % $ 171 M Nasdaq Global Select Market israelIsrael
Pharming Group N.V. Pharming Group N.V.
PHAR
 		$ 12.46 -3.63 % $ 8.58 B Nasdaq Global Select Market niderlandNiderland
NanoViricides NanoViricides
NNVC
 		$ 1.41 -1.4 % $ 28.5 M NYSE American usaUSA
Omeros Corporation Omeros Corporation
OMER
 		$ 18.17 -0.55 % $ 1.15 B Nasdaq Global Select Market usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
 		$ 1.33 -3.62 % $ 69.9 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.